Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Host factors and vaccine efficacy: Implications for COVID‐19 vaccines
Shahab Falahi, Azra Kenarkoohi
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1330-1335
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Two centuries of vaccination: historical and conceptual approach and future perspectives
David A. Montero, Roberto Vidal, Juliana Velasco, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 38
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
Rupsha Fraser, Aurelio Orta‐Resendiz, Alexander Mazein, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 4, pp. 255-267
Open Access | Times Cited: 35
Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis
Christopher Martin, Joshua Nazareth, Amar Jarkhi, et al.
EClinicalMedicine (2023) Vol. 58, pp. 101926-101926
Open Access | Times Cited: 23
COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
Aleksandra Anna Zasada, Aniela Darlińska, Aldona Wiatrzyk, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1786-1786
Open Access | Times Cited: 23
Immune Cells, Gut Microbiota, and Vaccines: A Gender Perspective
Pierluigi Rio, Mario Caldarelli, Monica Chiantore, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 526-526
Open Access | Times Cited: 12
Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes
Junqing Xie, Beatriz Mothe, Marta Alcalde Herraiz, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Reverse vaccinology approaches to design a potent multiepitope vaccine against the HIV whole genome: immunoinformatic, bioinformatics, and molecular dynamics approaches
Ava Hashempour, Nastaran Khodadad, Shokufeh Akbarinia, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Maternal COVID-19 infection and the fetus: Immunological and neurological perspectives
Shahab Falahi, Amir Abdoli, Azra Kenarkoohi
New Microbes and New Infections (2023) Vol. 53, pp. 101135-101135
Open Access | Times Cited: 13
Genome‐wide association studies of response and side effects to the BNT162b2 vaccine in Italian healthcare workers: Increased antibody levels and side effects in carriers of the HLA‐A*03:01 allele
Chiara Magri, Eleonora Marchina, Emanuele Sansone, et al.
HLA (2023) Vol. 102, Iss. 6, pp. 707-719
Open Access | Times Cited: 11
AI-driven covalent drug design strategies targeting main protease (m pro ) against SARS-CoV-2: structural insights and molecular mechanisms
Mohammad Hossein Haghir Ebrahim Abadi, Abdulrahman Ghasemlou, Fatemeh Bayani, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-29
Closed Access | Times Cited: 4
Predictors of Acute Kidney Injury (AKI) among COVID-19 Patients at the US Department of Veterans Affairs: The Important Role of COVID-19 Vaccinations
Lilia R. Lukowsky, Claudia Der‐Martirosian, Heather Northcraft, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 146-146
Open Access | Times Cited: 4
In silico analysis of human herpes virus-8 genome: a comparison of the K1, VR1, and VR2 regions for genotyping and global geographical distribution
Nastaran Khodadad, Tayebeh Hashempour, Shokufeh Akbarinia
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Long-term antibody trajectories after PPSV23 in elderly: Results from a 4-year follow-up study
Shanshan Zhou, Jian Wang, Min Lv, et al.
Vaccine (2025) Vol. 48, pp. 126737-126737
Closed Access
Diet, microbiome, and probiotics establish a crucial link in vaccine efficacy
Soumam Dutta, Niloy Chatterjee, Nicholas L. F. Gallina, et al.
Critical Reviews in Microbiology (2025), pp. 1-26
Open Access
Vaccination versus natural infection: A review of antibody differentiation techniques
Vaishnavi Mishra, Prashant Gupta, Nandkishor Bankar, et al.
Journal of Research in Medical Sciences (2025) Vol. 30, Iss. 1
Open Access
Psychometric Properties of the Bangla Version of the Vaccination Fear Scale (VFS-6): A Dual Approach of Classical and Modern Test Theory
Md. Hasanuzzaman, Md. Shajadul Islam, Md Hafizur Rahman, et al.
Clinical Epidemiology and Global Health (2025), pp. 102015-102015
Open Access
Impact of COVID-19 Vaccination on the Mortality Rates of Hospitalized Patients with the Omicron Strain
Rozita Khodashahi, Aref Abdollahzade, Mehrsa Vahdatinia, et al.
Archives of Clinical Infectious Diseases (2025) Vol. 20, Iss. 3
Open Access
Development of a personalized digital biomarker of vaccine-associated reactogenicity using wearable sensors and digital twin technology
Steven R. Steinhubl, Jadranka Sekaric, Maged Gendy, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
Quantitative risk assessment and interventional recommendations for preventing canine distemper virus infection in captive tigers at selected wildlife stations in Thailand
Kanittha Tonchiangsai, Anuwat Wiratsudakul, Suwicha Kasemsuwan, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0320657-e0320657
Open Access
SARS-CoV-2 Vaccines: Types, Working Principle, and Its Impact on Thrombosis and Gastrointestinal Disorders
Shubhra Khare, Niharika Niharika, Ajey Singh, et al.
Applied Biochemistry and Biotechnology (2022) Vol. 195, Iss. 2, pp. 1541-1573
Open Access | Times Cited: 15
Efficacy of the tetravalent protein COVID-19 vaccine, SCTV01E: a phase 3 double-blind, randomized, placebo-controlled trial
Ruizhi Zhang, Junshi Zhao, Xiaoping Zhu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations
Claudia Maria Trombetta, Giulia Piccini, Giulio Pierleoni, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 13
Immunogenicity of COVID‐19 mRNA vaccines in hemodialysis patients: Systematic review and meta‐analysis
Shahab Falahi, Hojjat Sayyadi, Azra Kenarkoohi
Health Science Reports (2022) Vol. 5, Iss. 6
Open Access | Times Cited: 12
Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials
Christine B. Turley, LaKesha Tables, Trevon Fuller, et al.
Vaccine (2023) Vol. 41, Iss. 33, pp. 4899-4906
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top